期刊文献+

CD_(31)、CD_(34)和CD_(105)蛋白在食管鳞状细胞癌组织微血管中的表达及意义 被引量:4

Expression and meanings of CD_(31),CD_(34) and CD_(105) protein in the tissue microvessel of esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨CD31、CD34和CD105蛋白表达在食管鳞状细胞癌(ESCC)发生、发展中的作用。方法应用免疫组化SP法对50例ESCC和10例正常食管黏膜组织标本进行标记染色,按Weidner法计算三种蛋白标记物的肿瘤组织微血管密度(MVD)。结果在ESCC及正常食管黏膜组织中MVD-CD31、MVD-CD34及MVD-CD105均依次降低,组间比较P<0.01;MVD-CD31、MVD-CD34与ESCC的浸润深度及淋巴结转移密切相关(P<0.05),MVD-CD105与ESCC的TNM分期、浸润深度及淋巴结转移密切相关(P<0.01);ESCC组织中MVD-CD31、MVD-CD34均显著高于MVD-CD105(P<0.01)。结论CD31、CD34和CD105蛋白表达在ESCC发生、发展和转移中起重要作用;联合检测三者可望为判断ESCC发展及利用血管抑制剂治疗提供理论依据。 Objective To investigate the effects of the expression of CD31 , CD34 and CD105 protein in the pathogenesis and development of esophageal squamous cell carcinoma(ESCC). Methods All the specimens'segments were stained by immunohistochemical SP method in 50 cases of ESCC tissue and 10 cases of normal esophageal epithelium, and then the microvessel density(MVD) marked by three protein were counted by the Weidner's method. Results The expression of MVD-CD31 ,MVD-CD34 and MVD-CD105 decreased by turns in ESCC and normal esophageal epithelium specimens. There was a significant difference among the groups (P 〈 0.01 ). The MVD-CD31 and MVD-CD34 were closely correlated with infiltration and lymphatic metastasis in ESCC ( P 〈 0.05 ). The MVD-CD105 was closely correlated with the TNM grade, infilatration and lymphatic metastasis in ESCC (P 〈 0.01 ). MVD-CD31 and MVD-CD34 were significantly higher than MVD-CD105 in ESCC tissue(P 〈0.01). Conclusions CD31, CD34 and CD105 protein may play important roles in the carcinogenesis, metastasis and infiltration of ESCC. United examination of these three protein is expected to determine the carcinogenesis of ESCC and provide theoretical evidence to the therapy by using vascular inhibitor.
出处 《山东医药》 CAS 北大核心 2009年第35期7-9,共3页 Shandong Medical Journal
基金 河南省杰出青年科学基金资助项目(074100510009) 河南省科技攻关计划项目资助项目(082102310011)
关键词 食管肿瘤 鳞状细胞癌 抗原 CD31 抗原 CD34 抗原 CD105 微血管密度 esophageal cancer, squamous cell carcinoma antigen, CD31 antigen, CD34 antigen, CD105 microvessel density
  • 相关文献

参考文献3

二级参考文献24

  • 1[1]Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen [J]. Science, 1989, 246: 1306- 1309.
  • 2[2]Volpert OV, Dameron KM, Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity [J]. Oncogene, 1997, 14: 1495- 1502.
  • 3[3]Weidner N. Intratumor microvessel density as a prognostic factor in cancer [J]. Am J Pathol, 1995, 147: 9- 19.
  • 4[4]Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin- binding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Commun, 1989, 161: 851- 858.
  • 5[5]Senger DR,Galli J, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[J]. Science (Washington DC), 1983, 219: 983- 985.
  • 6[6]Nagy JA, Brown LF, Senger DR, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition [J]. Biochem Biophys Acta, 1989, 948:305- 326.
  • 7[7]Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis [J]. Biochem Biophy Acta, 1990, 1032: 89- 118.
  • 8[8]Shibagaki L, Tanaka H, Shimada Y, et al. p53 mutation, murine double minute 2 amplification and human papillomavirus infection are frequently involved but not associated with each other in esophageal aquamous cell carcinoma [J]. Clin Cancer Res, 1995, 1: 769- 763.
  • 9[9]Kieser A, Weich HA, Brandner G, et al. Mutant p53 potentiates proteinkinase C induction of vascular endothelial growth factor expression [J]. Oncogene, 1994, 9: 963- 969.
  • 10[10]Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild- type p53 and v- Src exert opposing influence on human vascular endothelial growth factor gene expression [J]. Cancer Res, 1995, 74: 502- 507.

共引文献37

同被引文献61

  • 1宋曙,万政强,陈海涛.整合素β_1、FN与CD_(34)在脑胶质瘤中的表达及与预后的关系[J].山东医药,2009,49(52):17-19. 被引量:3
  • 2刘晓翌,夏东,张玉霞,肖晓素,张芳婷,杨飞,张银汉.大鼠肺癌癌变过程中癌组织内微血管的定量研究[J].现代肿瘤医学,2006,14(6):649-650. 被引量:6
  • 3刘宏斌,杨其昌,陈莉,季晓华,沈屹.乳腺癌中CD105的表达及其预后意义[J].南通大学学报(医学版),2006,26(6):435-437. 被引量:1
  • 4Rosai J.阿克曼外科病理学[M].9版.北京:北京大学医学出版社,2006:625-9.
  • 5Weider N.Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumors[J].Breast Cancer Res Treat,1995,36(2):169-80.
  • 6Li C,Issa R,Kumar P,et al.CD105 prevents apoptosis in hypoxic endothelial cells[J].J Cell Sci,2003,116(13):2677-85.
  • 7Akagi K,Ikeda Y,Sumiyoshi Y,et al.Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development[J].Surgery,2002,131(s1):109-13.
  • 8Saad R S,El-Gohary Y,Memari E,et al.Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma[J].Hum Pathol,2005,36(9):955-61.
  • 9Matsuno F,Haruta Y,Kondo M,et al.Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies[J].Clin Cancer Res,1999,5(2):371-82.
  • 10Lee S H,Mizutani N,Mizutani M,et al.Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer[J].Cancer Immunol Immunother,2006,55(12):1565-74.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部